Datamonitor, March 2011, Pages: 46
on the current treatment paradigm. Should both drugs successfully reach the market in 2011, triple combination therapy is set to become the new standard of care for patients infected with hepatitisC genotype 1
Decision Resources, Inc., July 2008, Pages: 25
in the HCV patient population, we built a simple market model based on estimations of the size of the treatment-eligible hepatitisC patient population in the United States, France, Germany, Italy, Spain
Ashgate Publishing, March 2010, Pages: 500
is associated with decreased risk for human immunodeficiency virus and hepatitisC virus: evidence from Amsterdam cohort studies among drug users, Charlotte van den Berg, Colette Smit, Giel van Brussel, Roel
Jain PharmaBiotech, Feb 2012, Pages: 864
in malaria
Identification of biomarkers in Schistosomiasis infections
Biomarkers of liver disease
Breath biomarkers of liver disease
Biomarkers of viral hepatitisB and C
Biomarkers of liver injury
Jain PharmaBiotech, Feb 2012, Pages: 1029
of indeterminate Western blot
Screening of cadaveric tissue donors
Tests used for quantification of HIV
Conclusions about HIV diagnostics
Hepatitis viruses
Hepatitis A virus
HepatitisB virus
HepatitisC
TriMark Publications, July 2011, Pages: 365
Distribution of Chronic HBV Infection
Figure 3.33: Rate of New Hepatitis A, B and C Infections in the U.S., 1982-2006
Figure 3.34: Global Prevalence of HepatitisC
Figure 3.35: Primary Causes of Chronic Liver
John Wiley and Sons Ltd, March 2007, Pages: 679
Female with Tremor, Depression, and Hepatitis (Steven I. Shedlofsky).
Case 13. Adult Male with New-Onset Ascites (Steven I. Shedlofsky).
Case 14. An Unexpected Finding . . . (Nathan C. Walk).
Case 15
Knowledge Press, Dec 2004
mutations, pathogenic organisms associated with diseases (HPV and cervical cancer, HepatitisB and liver cancer, etc), and disease-associated changes in RNA and protein expression levels. At present, Ribomed
